Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003580
Filing Date
2015-05-07
Accepted
2015-05-07 16:16:33
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20150331.htm 10-Q 1168192
2 EX-31.1 aldr-ex311_201503318.htm EX-31.1 11748
3 EX-31.2 aldr-ex312_201503317.htm EX-31.2 11744
4 EX-32.1 aldr-ex321_201503316.htm EX-32.1 8601
  Complete submission text file 0001564590-15-003580.txt   3989789

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20150331.xml EX-101.INS 527043
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20150331.xsd EX-101.SCH 19685
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20150331_cal.xml EX-101.CAL 28735
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20150331_def.xml EX-101.DEF 52194
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20150331_lab.xml EX-101.LAB 167128
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20150331_pre.xml EX-101.PRE 120772
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 15841965
SIC: 2834 Pharmaceutical Preparations